Correlation Between Celldex Therapeutics and T Rowe

Can any of the company-specific risk be diversified away by investing in both Celldex Therapeutics and T Rowe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celldex Therapeutics and T Rowe into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Celldex Therapeutics and T Rowe Price, you can compare the effects of market volatilities on Celldex Therapeutics and T Rowe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celldex Therapeutics with a short position of T Rowe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celldex Therapeutics and T Rowe.

Diversification Opportunities for Celldex Therapeutics and T Rowe

0.29

Correlation Coefficient

Celldex Therapeutics  T Rowe

Modest diversification

The 3 months correlation between Celldex and RRTLX is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and T Rowe Price in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T Rowe Price and Celldex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celldex Therapeutics are associated (or correlated) with T Rowe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T Rowe Price has no effect on the direction of Celldex Therapeutics i.e., Celldex Therapeutics and T Rowe go up and down completely randomly.

Pair Corralation between Celldex Therapeutics and T Rowe

Given the investment horizon of 90 days Celldex Therapeutics is expected to under-perform the T Rowe. In addition to that, Celldex Therapeutics is 6.68 times more volatile than T Rowe Price. It trades about -0.13 of its total potential returns per unit of risk. T Rowe Price is currently generating about -0.14 per unit of volatility. If you would invest  1,264  in T Rowe Price on September 29, 2024 and sell it today you would lose (54.00) from holding T Rowe Price or give up 4.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Celldex Therapeutics  vs.  T Rowe Price

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

T Rowe Price

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days T Rowe Price has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong essential indicators, T Rowe is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Celldex Therapeutics and T Rowe

The main advantage of trading using opposite Celldex Therapeutics and T Rowe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celldex Therapeutics position performs unexpectedly, T Rowe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T Rowe will offset losses from the drop in T Rowe's long position.

The idea behind Celldex Therapeutics and T Rowe Price pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.